Target type: biologicalprocess
Any process that activates or increases the frequency, rate or extent of the PERK-mediated unfolded protein response. [GO_REF:0000058, GOC:bf, GOC:PARL, GOC:TermGenie, PMID:22013210]
The unfolded protein response (UPR) is a cellular stress response activated by the accumulation of unfolded or misfolded proteins in the endoplasmic reticulum (ER). The PERK branch of the UPR is a key pathway involved in attenuating ER stress and restoring homeostasis. Positive regulation of PERK-mediated UPR involves a series of events that enhance PERK activation and downstream signaling.
1. **PERK dimerization and autophosphorylation:** Under normal conditions, PERK exists as an inactive monomer in the ER membrane. Accumulation of misfolded proteins in the ER lumen triggers PERK dimerization and autophosphorylation. This conformational change activates PERK's kinase activity.
2. **eIF2α phosphorylation:** Activated PERK phosphorylates the α subunit of eukaryotic initiation factor 2 (eIF2α). Phosphorylated eIF2α inhibits the translation initiation complex, leading to a global decrease in protein synthesis. This reduction in protein translation alleviates the stress on the ER by reducing the load of newly synthesized proteins.
3. **ATF4 expression:** The eIF2α phosphorylation also leads to increased translation of ATF4, a transcription factor that plays a critical role in the UPR. ATF4 promotes the expression of genes involved in ER stress response, including chaperones, foldases, and proteins involved in ER-associated protein degradation (ERAD).
4. **CHOP expression:** ATF4 also activates the expression of C/EBP homologous protein (CHOP). CHOP is a pro-apoptotic transcription factor that promotes cell death under prolonged ER stress. However, CHOP also contributes to the adaptation response by inducing autophagy, a process that removes misfolded proteins and organelles from the cell.
5. **ER chaperone expression:** ATF4 and other transcription factors activated during the UPR induce the expression of ER chaperones, such as glucose-regulated protein 78 (GRP78) and protein disulfide isomerase (PDI). These chaperones assist in protein folding and prevent aggregation of misfolded proteins.
6. **ERAD activation:** The UPR also activates ERAD, a pathway that removes misfolded proteins from the ER and targets them for degradation by the proteasome.
7. **Feedback regulation:** The UPR is tightly regulated through feedback mechanisms. As ER stress is alleviated and protein homeostasis is restored, the UPR signaling pathway is downregulated. This ensures that the UPR is activated only when necessary and does not disrupt normal cellular function.
8. **Modulation by other signaling pathways:** The PERK-mediated UPR can be influenced by other signaling pathways, such as the mTOR pathway and the MAPK pathway. These pathways can modulate the activity of PERK and the downstream signaling events, fine-tuning the UPR response to specific cellular conditions.'
"
Protein | Definition | Taxonomy |
---|---|---|
Tyrosine-protein phosphatase non-receptor type 2 | A tyrosine-protein phosphatase non-receptor type 2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P17706] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
5-iodo-2-(oxaloamino)benzoic acid | organoiodine compound | ||
lithocholic acid | lithocholate : A bile acid anion that is the conjugate base of lithocholic acid. lithocholic acid : A monohydroxy-5beta-cholanic acid with a alpha-hydroxy substituent at position 3. It is a bile acid obtained from chenodeoxycholic acid by bacterial action. Lithocholic Acid: A bile acid formed from chenodeoxycholate by bacterial action, usually conjugated with glycine or taurine. It acts as a detergent to solubilize fats for absorption and is itself absorbed. It is used as cholagogue and choleretic. | bile acid; C24-steroid; monohydroxy-5beta-cholanic acid | geroprotector; human metabolite; mouse metabolite |
glycyrrhetinic acid | cyclic terpene ketone; hydroxy monocarboxylic acid; pentacyclic triterpenoid | immunomodulator; plant metabolite | |
oleanolic acid | hydroxy monocarboxylic acid; pentacyclic triterpenoid | plant metabolite | |
vanadates | vanadate(3-) : A vanadium oxoanion that is a trianion with formula VO4 in which the vanadium is in the +5 oxidation state and is attached to four oxygen atoms. Vanadates: Oxyvanadium ions in various states of oxidation. They act primarily as ion transport inhibitors due to their inhibition of Na(+)-, K(+)-, and Ca(+)-ATPase transport systems. They also have insulin-like action, positive inotropic action on cardiac ventricular muscle, and other metabolic effects. | trivalent inorganic anion; vanadium oxoanion | EC 3.1.3.1 (alkaline phosphatase) inhibitor; EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor; EC 3.1.3.41 (4-nitrophenylphosphatase) inhibitor; EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor |
ursolic acid | hydroxy monocarboxylic acid; pentacyclic triterpenoid | geroprotector; plant metabolite | |
madecassic acid | monocarboxylic acid; pentacyclic triterpenoid; tetrol | antioxidant; plant metabolite | |
maslinic acid | (2Alpha,3beta)-2,3-dihydroxyolean-12-en-28-oic acid: from Luehea divaricata and Agrimonia eupatoria | dihydroxy monocarboxylic acid; pentacyclic triterpenoid | anti-inflammatory agent; antineoplastic agent; antioxidant; plant metabolite |
geniposide | terpene glycoside | ||
asiatic acid | monocarboxylic acid; pentacyclic triterpenoid; triol | angiogenesis modulating agent; metabolite | |
celastrol | monocarboxylic acid; pentacyclic triterpenoid | anti-inflammatory drug; antineoplastic agent; antioxidant; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; Hsp90 inhibitor; metabolite | |
cryptotanshinone | cryptotanshinone: from Salvia miltiorrhiza | abietane diterpenoid | anticoronaviral agent |
boswellic acid | boswellic acid: ursane type; RN given refers to (3alpha,4beta)-isomer; active principle of salai guggal; see also record for salai guggal | triterpenoid | |
procurcumenol | procurcumenol: RN given for (1S-(1alpha,3abeta,8aalpha))-isomer; epiprocurcumenol is the (1S-(1alpha,3aalpha,8aalpha))-isomer; a TNF-alpha antagonist isolated from Curcuma zedoaria; structure in first source | sesquiterpenoid | |
pinocembrin | |||
genipin | iridoid monoterpenoid | anti-inflammatory agent; antioxidant; apoptosis inhibitor; cross-linking reagent; hepatotoxic agent; uncoupling protein inhibitor | |
2-(oxaloamino)benzoic acid | (oxaloamino)benzoic acid | ||
chlorogenic acid | caffeoylquinic acid: Antiviral Agent; structure in first source chlorogenate : A monocarboxylic acid anion that is the conjugate base of chlorogenic acid; major species at pH 7.3. | cinnamate ester; tannin | food component; plant metabolite |
tocopherylquinone | tocopherylquinone: RN refers to (3R-(3R*,7R*,11R*))-isomer; structure | ||
illudalic acid | illudalic acid: isolated from Clitocybe illudens; structure in first source | ||
eupatoriopicrine | germacranolide | ||
2-amino-6-chloropurine | 6-chloroguanine : An organochlorine compound that is 7H-purin-2-amine substituted by a chloro group at position 6. 6-chloroguanine: an antimalarial that inhibits hypoxanthine-guanine-xanthine phosphoribosyltransferase; structure in first source | 2-aminopurines; organochlorine compound | |
corosolic acid | triterpenoid | metabolite | |
11-keto-boswellic acid | |||
3-epioleanolic acid | triterpenoid | metabolite | |
oleanonic acid | oleanonic acid: structure in first source | ||
zedoarondiol | zedoarondiol: structure in first source | ||
formylchromone | formylchromone: structure in first source | ||
rk 682 | |||
variabilin | variabilin: an RGD-containing antagonist of glycoprotein IIb-IIIa from the hard tick, Dermacentor variabilis; amino acid sequence given in first source |